Background Definitive chemoradiotherapy (CRT) is the standard treatment for locally
advanced head and neck cancer (HNC). However, for very elderly patients, the comparison …

BACKGROUND The overall survival (OS) benefit of concurrent chemoradiotherapy (CRT) for
head and neck squamous cell carcinoma patients older than 70 years is debated. This study …

Purpose Concurrent chemoradiotherapy (CRT) is the standard of care for many sites of
locally advanced head and neck squamous cell carcinomas (LAHNC). However, on meta …

Background Whether concurrent chemotherapy with radiotherapy (CRT) is effective for
elderly patients with head and neck cancer is a controversial topic. This study aimed to …

Objectives: This study aimed to assess the effect of definitive or adjuvant concurrent
chemoradiation (CRT) among elderly patients with locally advanced head and neck …

Background: The objective of this study was to assess the treatment outcomes and
prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) …

Background The reported decreasing benefit with increasing age from concurrent
chemoradiotherapy in head and neck cancer patients prompted this retrospective review …

Background. With the aging population and a rising incidence of squamous cell carcinoma
of the head and neck (SCCHN), there is an emerging need for developing strategies to treat …

Results A total of 5,265 patients were included: 3,604 (68%) received RT alone, and 1,661
(32%) received CRT. Median follow-up was 31 mo (2-181 mo). Median age of patients …

Purpose To report outcomes and predictive factors of overall survival, hospitalization and
treatment completion rates in elderly patients with locally advanced head and neck cancer …